391 related articles for article (PubMed ID: 28265031)
1. Phage therapy is highly effective against chronic lung infections with
Waters EM; Neill DR; Kaman B; Sahota JS; Clokie MRJ; Winstanley C; Kadioglu A
Thorax; 2017 Jul; 72(7):666-667. PubMed ID: 28265031
[TBL] [Abstract][Full Text] [Related]
2. The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airways.
Trend S; Fonceca AM; Ditcham WG; Kicic A; Cf A
J Cyst Fibros; 2017 Nov; 16(6):663-670. PubMed ID: 28720345
[TBL] [Abstract][Full Text] [Related]
3. Bacteriophage Therapy Increases Complement-Mediated Lysis of Bacteria and Enhances Bacterial Clearance After Acute Lung Infection With Multidrug-Resistant Pseudomonas aeruginosa.
Abd El-Aziz AM; Elgaml A; Ali YM
J Infect Dis; 2019 Apr; 219(9):1439-1447. PubMed ID: 30476337
[TBL] [Abstract][Full Text] [Related]
4. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C
mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480
[TBL] [Abstract][Full Text] [Related]
5. The effects of different doses of inhaled bacteriophage therapy for Pseudomonas aeruginosa pulmonary infections in mice.
Chang RYK; Chow MYT; Wang Y; Liu C; Hong Q; Morales S; McLachlan AJ; Kutter E; Li J; Chan HK
Clin Microbiol Infect; 2022 Jul; 28(7):983-989. PubMed ID: 35123053
[TBL] [Abstract][Full Text] [Related]
6. Synergy between the Host Immune System and Bacteriophage Is Essential for Successful Phage Therapy against an Acute Respiratory Pathogen.
Roach DR; Leung CY; Henry M; Morello E; Singh D; Di Santo JP; Weitz JS; Debarbieux L
Cell Host Microbe; 2017 Jul; 22(1):38-47.e4. PubMed ID: 28704651
[TBL] [Abstract][Full Text] [Related]
7. Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder Formulation.
Chang RYK; Chen K; Wang J; Wallin M; Britton W; Morales S; Kutter E; Li J; Chan HK
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158280
[TBL] [Abstract][Full Text] [Related]
8. Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status.
Hraiech S; Brégeon F; Rolain JM
Drug Des Devel Ther; 2015; 9():3653-63. PubMed ID: 26213462
[TBL] [Abstract][Full Text] [Related]
9. Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model.
Cafora M; Deflorian G; Forti F; Ferrari L; Binelli G; Briani F; Ghisotti D; Pistocchi A
Sci Rep; 2019 Feb; 9(1):1527. PubMed ID: 30728389
[TBL] [Abstract][Full Text] [Related]
10. Vaccination against respiratory Pseudomonas aeruginosa infection.
Grimwood K; Kyd JM; Owen SJ; Massa HM; Cripps AW
Hum Vaccin Immunother; 2015; 11(1):14-20. PubMed ID: 25483510
[TBL] [Abstract][Full Text] [Related]
11. A proposed integrated approach for the preclinical evaluation of phage therapy in Pseudomonas infections.
Danis-Wlodarczyk K; Vandenheuvel D; Jang HB; Briers Y; Olszak T; Arabski M; Wasik S; Drabik M; Higgins G; Tyrrell J; Harvey BJ; Noben JP; Lavigne R; Drulis-Kawa Z
Sci Rep; 2016 Jun; 6():28115. PubMed ID: 27301427
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation.
Yanagihara K; Tomono K; Sawai T; Kuroki M; Kaneko Y; Ohno H; Higashiyama Y; Miyazaki Y; Hirakata Y; Maesaki S; Kadota J; Tashiro T; Kohno S
J Antimicrob Chemother; 2000 Jul; 46(1):69-72. PubMed ID: 10882691
[TBL] [Abstract][Full Text] [Related]
13. Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice.
Vinodkumar CS; Kalsurmath S; Neelagund YF
Indian J Pathol Microbiol; 2008; 51(3):360-6. PubMed ID: 18723958
[TBL] [Abstract][Full Text] [Related]
14. Inhaled bacteriophage therapy in a porcine model of pneumonia caused by Pseudomonas aeruginosa during mechanical ventilation.
Guillon A; Pardessus J; L'Hostis G; Fevre C; Barc C; Dalloneau E; Jouan Y; Bodier-Montagutelli E; Perez Y; Thorey C; Mereghetti L; Cabrera M; Riou M; Vecellio L; Le Guellec S; Heuzé-Vourc'h N
Br J Pharmacol; 2021 Sep; 178(18):3829-3842. PubMed ID: 33974271
[TBL] [Abstract][Full Text] [Related]
15. Filamentous Bacteriophage Produced by Pseudomonas aeruginosa Alters the Inflammatory Response and Promotes Noninvasive Infection In Vivo.
Secor PR; Michaels LA; Smigiel KS; Rohani MG; Jennings LK; Hisert KB; Arrigoni A; Braun KR; Birkland TP; Lai Y; Hallstrand TS; Bollyky PL; Singh PK; Parks WC
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795361
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of the YH6 phage in a murine hemorrhagic pneumonia model.
Yang M; Du C; Gong P; Xia F; Sun C; Feng X; Lei L; Song J; Zhang L; Wang B; Xiao F; Yan X; Cui Z; Li X; Gu J; Han W
Res Microbiol; 2015 Oct; 166(8):633-43. PubMed ID: 26254772
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence.
Oechslin F; Piccardi P; Mancini S; Gabard J; Moreillon P; Entenza JM; Resch G; Que YA
J Infect Dis; 2017 Mar; 215(5):703-712. PubMed ID: 28007922
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of erythromycin inhalation in chronic respiratory infection caused by Pseudomonas aeruginosa].
Yanagihara K; Tomono K; Sawai T; Sasaki E; Kakeya H; Yamamoto Y; Ohno H; Ogawa K; Kadota J; Koga H; Kohno S; Hirakata Y; Tashiro T
Kansenshogaku Zasshi; 1997 Apr; 71(4):337-41. PubMed ID: 9164089
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of Pseudomonas aeruginosa location in the lungs of patients with cystic fibrosis.
Moore JE; Mastoridis P
J Clin Pharm Ther; 2017 Jun; 42(3):259-267. PubMed ID: 28374433
[TBL] [Abstract][Full Text] [Related]
20. Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos.
Cafora M; Forti F; Briani F; Ghisotti D; Pistocchi A
J Vis Exp; 2020 May; (159):. PubMed ID: 32478753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
